Semaglutide, the active ingredient in Wegovy, helps regulate appetite by slowing stomach emptying and signaling fullness to the brainbut this mechanism can cause temporary nausea, vomiting, and digestive upset in the first 24 weeks of treatment
Weve been working in the NHS since 2017, supporting people to lose weight and manage their type 2 diabetes
, , ,
Still, its entirely plausible that some people will experience an adverse effect on their mental health after taking Wegovy or other GLP-1 medications
not for human or veterinary use.
BlueCross BlueShield of Texas (BCBSTX) is the largest commercial carrier with roughly 35% market share, followed by UnitedHealthcare, Cigna, Aetna, and Humana